ITeos Therapeutics Inc (ITOS)
10.79
+0.19
(+1.79%)
USD |
NASDAQ |
Apr 26, 11:03
ITeos Therapeutics Shareholders Equity (Quarterly): 575.23M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 575.23M |
| September 30, 2023 | 598.26M |
| June 30, 2023 | 623.53M |
| March 31, 2023 | 652.26M |
| December 31, 2022 | 663.33M |
| September 30, 2022 | 634.20M |
| June 30, 2022 | 637.30M |
| March 31, 2022 | 626.38M |
| December 31, 2021 | 552.82M |
| Date | Value |
|---|---|
| September 30, 2021 | 372.04M |
| June 30, 2021 | 289.50M |
| March 31, 2021 | 312.61M |
| December 31, 2020 | 323.20M |
| September 30, 2020 | 335.63M |
| June 30, 2020 | 133.05M |
| March 31, 2020 | 139.45M |
| December 31, 2019 | -36.09M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-36.09M
Minimum
Dec 2019
663.33M
Maximum
Dec 2022
437.22M
Average
552.82M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences Inc | 22.83B |
| Merck & Co Inc | 37.58B |
| Arcus Biosciences Inc | 462.00M |
| IGM Biosciences Inc | 203.23M |
| Forian Inc | 26.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 667.59M |
| Total Liabilities (Quarterly) | 92.36M |